Novavax Could Be The Next Biotech Winner In COVID-19 Vaccines

Remarkable Comeback After Years Of Disappointment

 
• By Andrew McConaghie

After years of setbacks, Novavax is on the cusp of success with its COVID-19 vaccine - but a rapid scale up of manufacturing and commercial operations will be a huge challenge.

US vaccination centre
Novavax is seeing high levels of volunteers joining its US Phase III trial, despite FDA authorized COVID-19 vaccines already being available.

More from Business

More from Scrip